Frederick Beddingfield
Chief Executive Officer & Director Rubedo Life Sciences
Seminars
Thursday 5th November 2026
Panel Discussion: Bringing Cosmetic Dermatology Back into R&D & Addressing High Patient Demand Through Scientific Innovation
9:00 am
- Examining why conditions such as acne, female hair loss, skin aging and aesthetic restoration remain underrepresented in dermatology drug development, despite affecting millions of patients worldwide, to identify where innovation is most needed
- Exploring how advances in regenerative medicine, longevity science, muscle restoration, skin rejuvenation and hair biology are creating new opportunities beyond traditional inflammatory dermatology, to unlock the next generation of dermatology pipelines
- Debating how industry, academia and clinicians can elevate cosmetic dermatology from a procedure-driven market to a science-led therapeutic field, strengthening evidence generation, regulatory pathways and investment in high-unmet-need patient populations
Wednesday 4th November 2026
From 140 Million Cells to Human Trials: Applying AI & Human Tissue Biology to Accelerate Dermatology Drug Discovery
3:45 pm
- Building proprietary cellular atlases through advanced multi-omics approaches to reveal novel disease mechanisms and therapeutic opportunities
- Leveraging AI and machine learning to identify, prioritize and validate targets emerging from complex human biology datasets
- Sharing lessons from advancing an AI-discovered therapeutic from target identification to clinical studies in approximately half the traditional development timeline
